A new study, published recently in Nature Communications, offers the first-ever map of which parts of Chikungunya virus ...

More information: Rimjhim Agarwal et al, Identification of immunogenic and cross-reactive chikungunya virus epitopes for CD4+ T cells in chronic chikungunya disease, Nature Communications (2025 ...

A new study, published recently in Nature Communications , offers the first-ever map of which parts of Chikungunya virus trigger the ...

Chikungunya virus-specific CD4+ T cells are associated with chronic chikungunya viral arthritic disease in humans. Cell Reports Medicine, 2025; 6 (5): 102134 DOI: 10.1016/j.xcrm.2025.102134; ...

The study focused on blood samples from CHIKV patients in Colombia and found that even six years after initial infection, 87% of patients still had CD4+ T cells that specifically recognized the virus.

The chikungunya virus spreads to humans through mosquito bites and contact with blood. It is rarely fatal, but the symptoms can be long-lasting. Learn more here.

LA JOLLA, CA—Chikungunya virus (CHIKV) is a mosquito-borne pathogen that has been identified in more than 110 countries around the world. The virus typically causes flu-like symptoms, but it can ...

IRISH holidaymakers heading to a European sunshine spot this summer have been warned over new cases of a deadly “mosquito” ...

The virus-like particle chikungunya vaccine received accelerated approval from the FDA in February, and is one of two single-dose vaccines to prevent disease caused by the chikungunya virus.

Most of the locally-acquired cases of chikungunya appear to be clustered around two towns near Marseille, Toulon and ...

Due to climate change, many parts of Europe are facing longer and more intense mosquito seasons, with mosquito-borne ...